|
HS Code |
957406 |
| Productname | 2'-Bromo-2'-Deoxyuridine |
| Synonyms | BrdU, Bromodeoxyuridine |
| Casnumber | 59-14-3 |
| Molecularformula | C9H11BrN2O5 |
| Molecularweight | 307.10 g/mol |
| Appearance | White to off-white powder |
| Meltingpoint | 187-191°C |
| Solubility | Soluble in water and DMSO |
| Storagetemperature | 2-8°C |
| Purity | Typically ≥ 98% |
| Iupacname | 5-bromo-1-(2-deoxy-β-D-erythro-pentofuranosyl)uracil |
| Usage | Cell proliferation marker |
As an accredited 2'-Bromo-2'-Deoxyuridine factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.
| Packing | |
| Shipping | |
| Storage |
Competitive 2'-Bromo-2'-Deoxyuridine prices that fit your budget—flexible terms and customized quotes for every order.
For samples, pricing, or more information, please call us at +8615371019725 or mail to admin@sinochem-nanjing.com.
We will respond to you as soon as possible.
Tel: +8615371019725
Email: admin@sinochem-nanjing.com
Flexible payment, competitive price, premium service - Inquire now!
Scientists and life science professionals often look for tools that not only deliver results but positively change the pace and accuracy of research. Working in a molecular biology lab, I've come to talk about breakthroughs with colleagues, and someone always brings up the need for cleaner incorporation assays and more reliable cell cycle analyses. With that in mind, 2'-Bromo-2'-deoxyuridine, often called BrdU, deserves a closer look. It isn’t just another nucleoside analog; its impact on DNA labeling leaves a clear mark, both in the cells and in our understanding of cellular processes.
This compound carries a straightforward model: it resembles thymidine structurally, except for the substitution of a bromine atom at the 2' position of the deoxyribose ring. This change lets BrdU become a stand-in for thymidine during DNA synthesis. So whenever a cell splits, the BrdU slips seamlessly into new DNA, acting as a precise tracker. Over the years, I’ve seen countless protocols trust BrdU to take the guesswork out of measuring how quickly cells replicate and respond to treatment. Unlike older, radioactively labeled nucleotides, BrdU works without the health hazards or disposal headaches that used to dog every experiment.
What sets BrdU apart is its detection flexibility. Researchers can pick up its trail using a range of immunohistochemical and immunofluorescent methods, making it easier to choose the right balance between speed, cost, and detail. The process scales from a single tissue section on a slide to hundreds of samples across tissue arrays.
Labs usually seek BrdU in powder or crystalline form, with high purity levels to guarantee clean results in every batch. In my experience, many teams look for greater than 98% purity, which helps rule out false signals or toxicity concerns. The best batches dissolve well in water, making them easy to add to cell cultures or animal models. In the lab, stock solutions tend to run at 10 mg/mL, but this can change depending on the type of cells and protocols you follow.
Temperature sensitivity and light protection turn up often in the care instructions, based on times I've watched solutions lose their reputation in the fridge after weeks of waiting for an experiment to get going. Stored dry and shielded from light, the chemical lasts, keeping experiments consistent whether run today or next month.
Tracking cell proliferation isn’t just a matter of counting, it’s about understanding life at the most basic level. BrdU’s ability to label newly synthesized DNA makes it essential in research labs focused on cancer, neuroscience, immunology, and regenerative medicine. I recall one particular study tracking neural stem cell division in brain tissue, where BrdU provided a direct window into the birth and fate of new cells, shedding light on the pathologies of diseases like Alzheimer’s. Using BrdU, researchers can answer complicated questions about which cells actually undergo replication, and at what stage of disease or recovery those divisions occur.
The process involves adding BrdU to the culture medium or injecting it into animals. Over a set period, rapidly dividing cells take up BrdU. After harvesting the tissue or fixed cells, detection relies on anti-BrdU antibodies after denaturing the DNA, which exposes the substituted nucleoside for immunostaining. I’ve run these assays myself, and the clarity of the results genuinely determines whether you spend hours squinting at nonspecific background or confidently moving forward to quantification.
The market has seen other DNA analogs aiming to replace BrdU, so it’s worth weighing these options. BrdU’s most common counterpart in recent years is EdU, or 5-ethynyl-2'-deoxyuridine. EdU detection skips the DNA denaturation step, relying on copper-catalyzed “click chemistry” that targets the ethynyl group. This leaves cell structures more intact—a plus in sensitive tissues—but the copper reagent sometimes brings toxicity issues, especially in living cells. BrdU, using antibody-mediated detection, can be gentle if the protocol avoids harsh denaturation, and its well-established background means published results stack up across decades of evidence.
Some labs opt for radioactive thymidine, particularly for historic continuity or when dealing with protein synthesis rates, but the practical risks and disposal complications have pushed most groups away from radioactivity. BrdU, by contrast, needs only basic lab safety and can be handled by undergraduates or in facilities without specialty radiation oversight.
Labeling DNA solely through nucleoside analog uptake might not capture every nuance in certain systems. For organoid cultures and slow-cycling stem cells, dual-labeling methods—with BrdU combined with markers like Ki-67 or PCNA—improve the reliability of data. I’ve watched joint seminars where researchers debated BrdU’s long track record versus EdU’s convenience. Often, budget, time constraints, and the downstream assays tip the decision in one direction or another. BrdU’s lower cost per sample and robust history keep it a common choice.
Science hinges on reproducibility. Funding panels and journal reviewers expect rigorous tracking of cell proliferation and migration, especially in preclinical or drug development environments. BrdU’s legacy means that protocols, troubleshooting tips, and best practices are widely shared across conferences, publications, and training videos. If you need help, chances are a team in the next building has faced the same challenge and can offer advice based on direct experience. This kind of cross-pollination only comes with tools that have a long-standing role in core scientific workflows.
BrdU steps into clinical settings as well, playing a key role in understanding tumor growth, immune cell turnover, and the dynamics of wound healing. The ability to see which cells divide, and at what rate, guides decisions in oncology trials—sometimes influencing how doctors monitor a treatment’s effectiveness or predict relapse. I remember holding BrdU-stained tissue under a microscope and recognizing patterns that later shaped whole research directions.
In stem cell clinics and regenerative medicine start-ups, BrdU tracking often reveals whether cell therapy products truly engraft and expand within a host. Critics might note the limitations of BrdU’s short half-life in certain tissues, but for most applications with timed pulse labeling, it remains effective and cost-efficient.
Not all research tools earn reputations for safety, but BrdU generally stays well within the comfort zone. It asks for careful weighing, proper PPE, and attention to dust or spills, like any lab chemical. Toxicology studies point to cellular effects only at concentrations much higher than what thoughtful labs use. Troubles usually show up only when carelessness creeps in: letting it contaminate personal items or overusing it in animal studies. Chemical hygiene policies and awareness of potential irritation keep risks in check. For most of us, following basic protocols preserves both sample integrity and personal safety.
Occasional concerns come up about the mutagenic properties of nuleoside analogs, but widespread use in cell labeling, without significant harm to researchers or animal models, speaks to an overall favorable safety record. Over a decade, I’ve watched hundreds of students run BrdU assays with no incidents, so long as they treat it with the routine respect any lab reagent commands.
Over the years, sourcing BrdU has sometimes tested lab budgets and patience. Reliable suppliers keep consistency high, matching certificates of analysis with what shows up in practice. Labs often seek products manufactured under GMP or ISO guidelines, not just to meet grant requirements but to ensure the results they publish hold up to review. Counterfeit or low-grade products have appeared now and then, usually giving themselves away by failing to dissolve, clumping, or generating off-target stains. Quality assurance at every step—from raw chemicals to the finished product—matters just as much as the chemical structure listed on the bottle.
Price fluctuations also make a difference, forcing labs to plan ahead or adjust protocols during lean funding years. For educators or outreach coordinators trying to bring science to students, affordability of small quantities helps keep hands-on demos viable. Supply chain disruptions, which made headlines during global events like the COVID-19 pandemic, underscored how global sourcing and local storage make or break the ability to keep experiments on track. Few things frustrate a research team more than losing weeks or months to a backordered chemical.
One way to reduce headaches around BrdU is to establish shared purchasing across research groups. Several large institutions run resource centers or core facilities that bulk-order and redistribute high-quality BrdU, passing savings down to individual principal investigators. By building relationships with reliable distributors, these centers keep stock fresh, avoid surprises in shipping or expiry dates, and negotiate consistent pricing.
Better training in handling and storage can also stave off lost experiments. Many labs create protocols with clear reminders about light protection, labeling, and documentation, ensuring future users don’t have to reinvent the wheel. I’ve seen simple steps like wrapping vials in foil and logging open dates save months of troubleshooting down the line.
While BrdU delivers strong labeling specificity, detection depends on a suite of commercially available antibodies. Choosing the right antibody, at the correct dilution, often makes the difference between a publishable image and a project headed for repeat staining. Lot-to-lot antibody variation sometimes creates frustrations, so some groups advocate for stockpiling proven lots or validating new lots in pilot assays.
Troubleshooting protocols frequently address concerns about cross-reactivity with DNA repair or certain non-proliferative tissue types. Mild acid or enzymatic DNA denaturation conditions minimize artifacts, but as with all immunodetection, careful controls and validation matter. Teams that use both positive and negative reference samples find it easier to publish convincing figures.
Using traditional reagents sometimes left a troubling legacy in university labs—radioactive waste bins and disposal fees. BrdU, in contrast, produces only a low-level chemical waste that most research institutions manage in standard non-radioactive streams. Being able to label large numbers of samples without fighting regulatory headaches keeps projects moving, particularly for early-career scientists, educators, or community outreach initiatives.
Education around environmentally sound handling practices—such as washing glassware before disposal and segregating chemical waste—helps reinforce good citizenship in the next generation of scientists. I’ve seen schools and summer camps safely use dilute BrdU in teaching, all while maintaining best practices for cleanup and documentation.
Some trends come and go in science, but BrdU continues to find a place in experiments probing cancer, stem cell dynamics, and tissue development. Familiarity breeds efficiency, so labs using BrdU often achieve faster turnaround times for projects, confident that protocols won’t require weeks of optimization.
In collaborative projects—whether multicenter clinical research or cross-disciplinary university teams—the shared language of BrdU labeling lets researchers spend their time driving discovery, not reconciling different tracking methods. Few compounds can claim such broad uptake and longevity in the research world.
BrdU’s role extends beyond established labs to welcoming undergraduates, interns, and novice technicians into the world of molecular biology. Open-access protocols, video tutorials, and shared datasets make the transition from textbook to lab bench far smoother. I remember my own early days, pipetting BrdU and learning the value of careful measurement, timing, and critical thinking—skills that form the backbone of good scientific practice.
Courses built around BrdU detection help introduce students to immunocytochemistry, microscopy, and data analysis. The relatively low hazard level and clear results mean that students see the impact of their actions and cherish the experiments, rather than feeling overwhelmed by complexity or risk.
As new types of microscopy, multiplex assays, and single-cell sequencing evolve, BrdU stands ready to be paired with emerging technologies. Researchers now use BrdU staining alongside fluorescent proteins or single-molecule FISH probes to measure cell cycle kinetics alongside gene expression. In the last few years, high-throughput platforms have integrated BrdU detection, allowing for automation and machine learning–based quantification.
Debates continue about preserving tissue morphology versus maximizing labeling sensitivity, but BrdU’s robust chemistry supports a range of adjustments, from gentle acid denaturation to harsher enzymatic approaches. This adaptability means fewer dead ends and more reliable workflows, even as scientific questions become more complex.
What gives BrdU its lasting value isn’t just chemistry—it’s the community of scientists, educators, and students who have refined and shared their experiences. Workshops, online forums, and troubleshooting guides build a living library of “what works and what doesn’t.” If you hit a snag, crowd-sourced solutions or published troubleshooting tips often get experiments back on track long before calling technical support. In my own work, the stories of saved projects or clever workarounds always begin with someone having faced the same challenge and sharing what they learned.
With the push for reproducibility and open science, BrdU’s clear performance profile helps projects meet funding and publication standards. It supports transparency—every step is well documented and open to audit, crucial when answering to review committees or regulatory bodies. Even in contested fields, such as cell therapy or controversial areas of developmental biology, BrdU tracking ensures that project data can stand scrutiny. My own experiences with multi-site studies show that teams achieve smoother approvals and clearer milestones when protocols depend on recognized, validated reagents.
BrdU has shaped the journey of life science research, not through hype or marketing, but through repeated, reliable impact. It supports both foundational work and bold new directions, opening windows onto the choreography of living cells. Those who use it understand that solid science stems from clear methods, strong communities, and a bit of hard-earned wisdom from the bench.
From undergraduate classrooms to clinical research hubs, BrdU continues to drive meaningful discovery—evidence that, in the fast-paced world of research, the right fundamentals keep science honest, creative, and forward looking. As new methods and models arise, BrdU remains a reliable companion, linking tradition with exploration and helping each new generation of scientists find their stride.